Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vancomycin Disposition in Neonates
NCT02096536Phase 4Recruiting
- Sponsor
- UZ Leuven
- Start
- Apr 2014
- Primary completion
- Jan 2025
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vancomycin in neonatal infection, sponsored by UZ Leuven. Started Apr 2014; status: recruiting.
02
Drugs
vancomycin
03
Conditions
neonatal infection
Beyond the preview
Go deeper on NCT02096536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02096536.